Viswanathan Ravi

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Viswanathan Ravi
CIK #0001479386
EDGAR Form CIK 2011 - 2026
3 [0001479386]
4 [0001479386]
Form 3/4/5 Subject 2011 - 2026
Viswanathan Ravi
Duolingo Inc
NewView Capital Partners I LLC
NewView Capital Fund I LP
Kerins Patrick J
Baskett Forest
Barris Peter J
Barrett M James
NEA 13 GP Ltd
NEA Partners 13 Limited Partnership
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Duolingo Inc DUOL
Class A Common Stock
2022-07-08 Other 11,466 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-07-08 Other 2,200 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-07-08 Other 11,466 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-07-08 Other 1,000,000 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-06-24 Other 5,733 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-06-24 Other 1,097 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-06-24 Other 5,733 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-06-24 Other 500,000 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-03-24 Other 11,467 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-03-24 Other 1,000,000 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-03-24 Other 2,194 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-03-24 Other 11,467 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-02-15 Other 1,096 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-02-15 Other 5,732 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-02-15 Other 5,732 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-02-15 Other 500,000 $0.00
Duolingo Inc DUOL
Class A Common Stock
2022-02-09 Conversion 5,239,835
Duolingo Inc DUOL
Class B Common Stock · derivative
2022-02-09 Conversion 5,239,835
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series C-1 Preferred Stock · derivative
2018-10-22 Option exercise 181,190 $0.00
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
2018-10-22 Sell 1,177 $5.00 5,885
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com